Could boron-containing compounds (BCCs) be effective against SARS-CoV-2 as anti-viral agent?

Cetiner E., Sayin K., Tuzun B., ATASEVEN H.

BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, cilt.122, sa.4, ss.263-269, 2021 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 122 Sayı: 4
  • Basım Tarihi: 2021
  • Doi Numarası: 10.4149/bll_2021_044
  • Dergi Adı: BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, EMBASE, MEDLINE
  • Sayfa Sayıları: ss.263-269
  • Anahtar Kelimeler: boronate ester, dioxaborole, in silico, SARS-CoV-2, MD calculations, DOCKING, GLIDE
  • Sivas Cumhuriyet Üniversitesi Adresli: Evet

Özet

BACKGROUND: Seven dioxaborole compounds are investigated in this study. Structural and spectral characterizations are done at the M062X/6-31+G(d,p) level in water. Active sites of these compounds are determined by contour plots of frontier molecular orbital and molecular electrostatic potential (MEP) maps. Electrophilic and nucleophilic attack regions are determined. Since SARS-CoV-2 is a worldwide health problem, antiviral properties of studied boron-containing compounds are investigated by molecular docking calculations. In addition to these calculations, MM/PSBA calculations are performed. RESULTS AND CONCLUSION: It is found that the studied boron compounds can be good drug candidates against the main protease of SARS-CoV-2, while the best of them is 4,6-di-tert-butyl-2-(4-methoxyphenyl) benzo[d][1,3,2] dioxaborole (B2) (Tab. 3, Fig. 8, Ref. 23). Text in PDF www.elis.sk